Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.56
-0.10 (-3.76%)
At close: Aug 15, 2025, 3:59 PM
2.57
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT

Orchestra BioMed Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.94M 2.89M 2.64M 2.65M 2.08M 2.22M 2.76M 3.6M 4.34M 3.83M 3.53M -23K 147K -1.23M -782K 1.67M 338K 1.32M
Cost of Revenue
216K 214K 278K 303K 276K 286K 222K 192K 207K 213K 211K 216K 204K 206K 199K 141K 97K 35K
Gross Profit
2.73M 2.67M 2.36M 2.34M 1.8M 1.93M 2.54M 3.41M 4.14M 3.62M 3.32M -239K -57K -1.44M -981K 1.53M 241K 1.28M
Operating Income
-71.27M -68.8M -64.3M -60.1M -58.29M -54.38M -51.51M -39.9M -26.19M -20.87M -14.45M -13.67M -12.95M -5.41M -394.75K -302.71K -208.27K -111.95K
Interest Income
1.6M 2.51M 3.36M 3.94M 3.94M 3.98M 4.2M 3.56M 2.77M 1.83M 596.62K 376.62K 433K 727K 927K 678K 494K 200K
Pretax Income
-69.7M -66.32M -61.02M -57.69M -55.58M -51.64M -49.12M -37.18M -24.55M -20.35M -15.14M -14.35M -13.75M -6M -378.75K -290.74K -200.33K -108K
Net Income
-69.7M -66.32M -61.02M -57.69M -55.58M -51.64M -49.12M -37.18M -24.55M -20.35M -15.14M -14.35M -13.75M -6M -378.75K -290.74K -200.33K -108K
Selling & General & Admin
24.09M 24.3M 23.86M 22.11M 22.78M 21.63M 20.22M 16.95M 11.42M 9.05M 7.11M 6.33M 5.61M 2.76M 394.76K 302.71K 208.27K 111.95K
Research & Development
49.9M 47.17M 42.8M 40.34M 37.31M 34.68M 33.82M 32.85M 30.2M 26.73M 21.95M 17.93M 15.69M 13.3M 12.89M 9.36M 5.7M 3.06M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
74M 71.47M 66.66M 62.45M 60.09M 56.31M 54.04M 42.26M 28.17M 22.33M 15.62M 14.83M 14.11M 6.23M 394.76K 302.71K 208.27K 111.95K
Interest Expense
-36K n/a n/a n/a n/a n/a 351K 351K 351K 597K 246K 246K 246K n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
74.21M 71.69M 66.94M 62.75M 60.37M 56.6M 54.27M 42.4M 28.27M 22.43M 15.72M 14.93M 14.22M 6.28M 394.76K 302.71K 208.27K 111.95K
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a -70K -124K -124K -124K -54K n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
38.39M 38.24M 38.06M 37.62M 35.8M 35.78M 35.78M 35.24M 34.61M 27.64M 23.3M 23.3M 31.61M 31.61M 20.45M 20.45M 20.45M 20.45M
Shares Outstanding (Diluted)
38.39M 38.24M 38.06M 37.62M 35.8M 35.78M 35.78M 35.24M 34.61M 27.64M 23.3M 23.3M 31.61M 31.61M 20.45M 20.45M 20.45M 20.45M
EPS (Basic)
-1.82 -1.77 -1.66 -1.6 -1.57 -1.47 -1.49 -1.17 -0.82 -0.72 -0.5 -0.46 -0.44 -0.19 -0.02 -0.01 -0.01 -0.01
EPS (Diluted)
-1.82 -1.77 -1.66 -1.6 -1.57 -1.47 -1.49 -1.17 -0.82 -0.72 -0.5 -0.46 -0.44 -0.19 -0.02 -0.01 -0.01 -0.01
EBITDA
-71.11M -68.56M -63.99M -59.81M -58M -54.09M -51.22M -48.57M -44.13M -38.83M -32.44M -30.54M -24.86M -22.82M -21.62M -13.76M -9.42M -3.88M
EBIT
-71.1M -68.63M -64.3M -60.1M -58.29M -54.38M -51.51M -48.85M -44.4M -39.07M -32.66M -22.92M -12.94M -5.4M -378.76K -290.74K -200.33K -108K
Depreciation & Amortization
243K 317K 308K 296K 291K 448K 600K 598K 581K 400K 222K 200K 192K 186K 181K 133K 87K 43K